These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 5305356
1. [Clinical significance of the use of antifibrinolytic agents]. Czuczor H, Vecsey D, Bánkuti P. Orv Hetil; 1969 Apr 27; 110(17):966-9. PubMed ID: 5305356 [No Abstract] [Full Text] [Related]
2. [On the use of antifibrinolytic agents in urology]. Rosdy E, Biró J, Szendröi Z, Szabó V. Acta Chir Acad Sci Hung; 1969 Apr 27; 10(1):25-35. PubMed ID: 5800598 [No Abstract] [Full Text] [Related]
4. [Hemostatic effect of "coagumin" in clinical use]. Kuze M, Kashiwagi T, Okita J, Komiya T, Nihira H. Hinyokika Kiyo; 1966 Jun 15; 12(6):576-82. PubMed ID: 6006918 [No Abstract] [Full Text] [Related]
5. The effects of trasylol and aminocaproic acid in post-prostatectomy haemorrhage. Pearson BS. Br J Urol; 1969 Oct 15; 41(5):602. PubMed ID: 5309948 [No Abstract] [Full Text] [Related]
6. Trasylol therapy of haemorrhage in surgical patients. Amris CJ. Acta Chir Scand Suppl; 1967 Oct 15; 378():45-52. PubMed ID: 5300106 [No Abstract] [Full Text] [Related]
7. [Surgical complications caused by fibrinolysis and their treatment following prostate surgery]. Wölfer E, Mihalecz K, Karátson A, Nagy I. Z Urol Nephrol; 1967 Dec 15; 60(12):853-7. PubMed ID: 4174722 [No Abstract] [Full Text] [Related]
9. Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience. Nilsson IM, Andersson L, Björkman SE. Acta Med Scand Suppl; 1966 Apr 01; 448():1-46. PubMed ID: 5221699 [No Abstract] [Full Text] [Related]
10. [The use of antifibrinolytic drugs (epsilon-amino caproic acid and Trasylol) in prostatic surgery]. Carbone G, Di Grazia G. Arch Ital Urol; 1966 Nov 01; 39(1):3-16. PubMed ID: 4172061 [No Abstract] [Full Text] [Related]
11. [Acute fibrinolysis after prostatectomy]. Aiello D. Sicil Sanit; 1966 Nov 01; 3(1):24-9. PubMed ID: 5296527 [No Abstract] [Full Text] [Related]
12. [Antifibrinolytic therapy in obstetrics and gynecology]. Schild W. Gynaecologia; 1965 Nov 01; 160(1):39-48. PubMed ID: 5294537 [No Abstract] [Full Text] [Related]
13. [Epsilon-aminocaproic acid and trasylol as hemostyptic agents in prostatic surgery]. Schmutzler R, Fürstenberg H. Helv Chir Acta; 1966 Aug 01; 33(4):478-83. PubMed ID: 5300406 [No Abstract] [Full Text] [Related]
14. [Treatment of hematuria in hemorrhagic diathesis by means of epsilon-aminocaproic acid with concomitant determination of urokinase]. Cohen I, Djaldetti M, Gorshein D, de Vries A. Folia Clin Int (Barc); 1965 Nov 01; 15(11):537-8. PubMed ID: 5867570 [No Abstract] [Full Text] [Related]
15. Control of bleeding during and after prostatectomy. Fam A. Int Surg; 1971 Nov 01; 56(5):352-61. PubMed ID: 5315847 [No Abstract] [Full Text] [Related]
16. [The use of epsilon-aminocaproic acid in urology]. Oberst O. Z Urol Nephrol; 1965 Nov 01; 58(10):717-25. PubMed ID: 5866679 [No Abstract] [Full Text] [Related]
17. [Essential hematuria and its treatment with fibrinolysis inhibitors]. Zhila VV. Vrach Delo; 1968 Feb 01; 2():82-5. PubMed ID: 5669369 [No Abstract] [Full Text] [Related]
18. [Fibrinolytic bleedings in urology]. Lipsky H, Hubmer O. Z Urol Nephrol; 1969 Feb 01; 62(6):453-61. PubMed ID: 5314209 [No Abstract] [Full Text] [Related]
19. Amicar and hyperfibrinolysis. Med Lett Drugs Ther; 1967 Jan 10; 9(3):10-1. PubMed ID: 6067964 [No Abstract] [Full Text] [Related]
20. [On local treatment of hemorrhages following prostatectomy with antifibrinolytic agents]. Vecsey D, Bánkuti P, Czuczor H. Z Urol Nephrol; 1967 Dec 10; 60(12):831-5. PubMed ID: 5302248 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]